Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1991;84:708-711

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ridker, P. M.
Right arrow Articles by Hennekens, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ridker, P. M.
Right arrow Articles by Hennekens, C. H.

Circulation, Vol 84, 708-711, Copyright © 1991 by American Heart Association


ARTICLES

Clinical characteristics of nonfatal myocardial infarction among individuals on prophylactic low-dose aspirin therapy

PM Ridker, JE Manson, JE Buring, SZ Goldhaber and CH Hennekens
Division of Cardiology, Brigham and Women's Hospital, Brookline, MA 02215.

BACKGROUND. The influence of prophylactic low-dose aspirin on the clinical characteristics of subsequent nonfatal myocardial infarction was examined in the Physicians' Health Study, a randomized, double- blind placebo-controlled trial of alternate-day aspirin (325 mg) among 22,071 US male physicians. METHODS AND RESULTS. During 60.2 months of follow-up, 342 incident cases of nonfatal myocardial infarction were confirmed (95.2% of all reports): 129 on aspirin and 213 on placebo (p less than 0.00001). Despite this statistically extreme reduction in occurrence of a first nonfatal infarction attributable to aspirin, there were no significant differences in the size, location, electrocardiographic features, or postinfarction left ventricular ejection fraction between the aspirin and placebo groups. Furthermore, among those undergoing angiography, there were no differences in the distribution or number of coronary vessels obstructed. CONCLUSIONS. These data indicate that chronic platelet inhibition with alternate-day aspirin therapy reduces the risk of a first myocardial infarction but does not appear to have a significant effect on the clinical characteristics of events that are survived. This finding may result from a direct effect of aspirin or from an aspirin-induced shift in infarction severity. Regardless of mechanism, these clinical observations suggest that treatment decisions for acute infarction patients should be made independently of a history of aspirin use.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
E. L. Portnay, J. M. Foody, S. S. Rathore, Y. Wang, F. A. Masoudi, J. P. Curtis, and H. M. Krumholz
Prior Aspirin Use and Outcomes in Elderly Patients Hospitalized With Acute Myocardial Infarction
J. Am. Coll. Cardiol., September 20, 2005; 46(6): 967 - 974.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. L. Wilterdink, B. Bendixen, H. P. Adams Jr, R. F. Woolson, W. R. Clarke, and M. D. Hansen
Effect of Prior Aspirin Use on Stroke Severity in the Trial of Org 10172 in Acute Stroke Treatment (TOAST)
Stroke, December 1, 2001; 32(12): 2836 - 2840.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. G. Frederick, O. D. Suleymanov, J. A. Szalony, B. B. Taite, A. K. Salyers, L. W. King, L. P. Feigen, and N. S. Nicholson
Protective Effect of Oral Xemilofiban in Arterial Thrombosis in Dogs : Increased Activity in Combination With Aspirin
Circulation, August 25, 1998; 98(8): 813 - 820.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
E. J. Weiss, P. F. Bray, M. Tayback, S. P. Schulman, T. S. Kickler, L. C. Becker, J. L. Weiss, G. Gerstenblith, and P. J. Goldschmidt-Clermont
A Polymorphism of a Platelet Glycoprotein Receptor as an Inherited Risk Factor for Coronary Thrombosis
N. Engl. J. Med., April 25, 1996; 334(17): 1090 - 1094.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Garcia-Dorado, P. Theroux, P. Tornos, A. Sambola, J. Oliveras, M. Santos, and J. S. Soler
Previous Aspirin Use May Attenuate the Severity of the Manifestation of Acute Ischemic Syndromes
Circulation, October 1, 1995; 92(7): 1743 - 1748.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
N. F. Col, J. Yarzebski, J. M. Gore, J. S. Alpert, and R. J. Goldberg
Does Aspirin Consumption Affect the Presentation or Severity of Acute Myocardial Infarction?
Arch Intern Med, July 10, 1995; 155(13): 1386 - 1389.
[Abstract] [PDF]